Codem, 16.36% Rise Amid Immune Checkpoint Inhibitor Theme Uptrend

On the 11th, the immuno-oncology theme rose by 3.10% compared to the previous day, showing strength, while Codem, a related stock attracting attention, surged by 16.36% compared to the previous day. Codem is known as a semiconductor and display manufacturing equipment company.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Codem's quant financial score was 8.99 points, ranking 15th in the quant financial ranking within the immuno-oncology theme. This can be interpreted as Codem having relatively low investment attractiveness from a financial perspective. On the other hand, Dong-A ST ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.